-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Courses
-
2 Articles
-
1 Photos
-
0 Vidéos
-
SEO à DengyueMed
-
Habitant HongKong
-
Du hongkong
-
Suivi par 0 membre
Mises à jour récentes
-
Luvometinib: A New Exploration in Targeted Therapy, from MET-Abnormal Lung Cancer to Multi-Cancer LayoutIn the field of oncology targeted therapy, the development of precision drugs for specific gene abnormalities has always been a key direction for breaking through challenges and extending patient survival. DengyuePharma has discovered that Luvometinib (trade name: Fumaining®), an independently developed Class 1 innovative drug by Fosun Pharma, stands out in the treatment of MET gene...0 Commentaires 0 Parts 8 Vue 0 AperçuConnectez-vous pour aimer, partager et commenter!
-
0 Commentaires 0 Parts 1 Vue 0 Aperçu
Plus de lecture